These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 315444)
1. The use of HLA-B27 in rheumatic diseases. Pascucci RA; Cummings NA J Ky Med Assoc; 1979 Sep; 77(9):455-8. PubMed ID: 315444 [No Abstract] [Full Text] [Related]
2. Histocompatibility antigens and rheumatic diseases. Calabrese LH; Clough JD; Braun WE J Am Osteopath Assoc; 1978 Nov; 78(3):192-8. PubMed ID: 309882 [No Abstract] [Full Text] [Related]
3. [Diagnostic significance of the occurrence of tissue antigen HLA-B27 in various rheumatic diseases]. Kuthan F; Streda A; Parma R; Krepelková M; Hill Z; Valnícková Z Vnitr Lek; 1979 Jun; 25(6):578-3. PubMed ID: 313621 [No Abstract] [Full Text] [Related]
4. The significance of the HL-AB27 antigen in a rheumatologic practice. Weaver AL; Cooley DA Nebr Med J; 1976 May; 61(5):154-7. PubMed ID: 1083491 [No Abstract] [Full Text] [Related]
5. The clinical spectrum of HLA-B27 related rheumatic diseases in India. Malaviya AN; Mehra NK; Adhar GC; Jindal K; Bhargava S; Batta RK; Vaidya MC; Tandon RK; Sankaran B J Assoc Physicians India; 1979 Jun; 27(6):487-92. PubMed ID: 528505 [No Abstract] [Full Text] [Related]
7. Clinical application of the HLA-B27 test in rheumatic diseases. A current perspective. Khan MA Arch Intern Med; 1980 Feb; 140(2):177-80. PubMed ID: 6986127 [TBL] [Abstract][Full Text] [Related]
8. [Initial manifestations of chronic inflammatory rheumatism in children associated with the presence of HLA-B27 antigen]. Prieur AM; Louis JJ; Thollot F; Micheau M; Regou F; Le Gall E; Despert F; Fontaine JL; Mazingue F Rev Rhum Mal Osteoartic; 1983 Dec; 50(12):807-11. PubMed ID: 6607506 [No Abstract] [Full Text] [Related]
10. The major histocompatibility complex and rheumatic diseases. Kemple K; Bluestone R Pathobiol Annu; 1977; 7():305-26. PubMed ID: 145574 [No Abstract] [Full Text] [Related]
11. [Histocompatability antigens in rheumatic diseases]. Tannenbaum H Union Med Can; 1976 Apr; 105(4):581-4. PubMed ID: 793131 [No Abstract] [Full Text] [Related]
12. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases. Dequeker J; Decock T; Walravens M; Van de Putte I J Rheumatol; 1978; 5(4):452-9. PubMed ID: 739494 [TBL] [Abstract][Full Text] [Related]
13. [B27-positive diseases. A new concept in rheumatology (author's transl)]. Schattenkirchner M; Krüger K; Herzer P MMW Munch Med Wochenschr; 1980 Nov; 122(48):1725-8. PubMed ID: 6779137 [TBL] [Abstract][Full Text] [Related]
15. Use of the HLA B27 test in Auckland. Thomas MG; Hart HH; Grigor RR; Gow PJ; Moore TE N Z Med J; 1984 Oct; 97(765):686-8. PubMed ID: 6333007 [TBL] [Abstract][Full Text] [Related]
16. Hitherto assembled results with the assessment of HLA antigens in rheumatic diseases and their impact. Dostál C; Ivasková E; Tesárek B; Hána I Czech Med; 1979; 2(1-2):56-63. PubMed ID: 316761 [TBL] [Abstract][Full Text] [Related]
17. [Reactive arthritis: the status of the problem and the outlook]. Agababova ER Revmatologiia (Mosk); 1985; (1):3-6. PubMed ID: 3890080 [No Abstract] [Full Text] [Related]
18. The HLA system and the rheumatic diseases. Marcelli-Barge A; Legrand L; Poirier JC; Schmid M; Dausset J Eur J Rheumatol Inflamm; 1982; 5(4):406-22. PubMed ID: 6983960 [No Abstract] [Full Text] [Related]
19. Editorial: HL-A system and rheumatic diseases. Danilevicius Z JAMA; 1975 Jan; 231(3):283. PubMed ID: 1078584 [No Abstract] [Full Text] [Related]
20. [Value of HL-A groups in diagnosis in rheumatology]. Seignalet J; Sany J; Serre H Rev Rhum Mal Osteoartic; 1975 Feb; 42(2):75-83. PubMed ID: 1079368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]